Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Nov 16:2013:1568-77.
eCollection 2013.

Exploring the relationship between drug side-effects and therapeutic indications

Affiliations
Comparative Study

Exploring the relationship between drug side-effects and therapeutic indications

Ping Zhang et al. AMIA Annu Symp Proc. .

Abstract

Therapeutic indications and drug side-effects are both measureable human behavioral or physiological changes in response to the treatment. In modern drug development, both inferring potential therapeutic indications and identifying clinically important drug side-effects are challenging tasks. Previous studies have utilized either chemical structures or protein targets to predict indications and side-effects. In this study, we compared indication prediction using side-effect information and side-effect prediction using indication information against models using only chemical structures and protein targets. Experimental results based on 10-fold cross-validation, show that drug side-effects and therapeutic indications are the most predictive features for each other. In addition, we extracted 6,706 statistically highly correlated disease-side-effect pairs from all known drug-disease and drug-side-effect relationships. Many relationship pairs provide explicit repositioning hypotheses (e.g., drugs causing postural hypotension are potential candidates for hypertension) and clear adverse-reaction watch lists (e.g., drugs for heart failure possibly cause impotence). All data sets and highly correlated disease-side-effect relationships are available at http://astro.temple.edu/~tua87106/druganalysis.html.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Statistics of the side-effect dataset. (a) The number of side-effects per drug. (b) The number of drugs per side-effect.
Figure 2.
Figure 2.
Statistics of the therapeutic-indication dataset. (a) The number of therapeutic indications per drug. (b) The number of drugs per therapeutic indication.
Figure 3.
Figure 3.
Illustration of the proposed method.
Figure 4.
Figure 4.
The averaged ROC comparison of therapeutic indication predictions for various information source combinations using in 10-fold cross validation. Information sources are sorted in legend of the figure according to their AUC score.
Figure 5.
Figure 5.
The averaged ROC comparison of drug side-effect predictions for various information source combinations using in 10-fold cross validation. Information sources are sorted in legend of the figure according to their AUC score.
Figure 6.
Figure 6.
Statistics of the highly correlated disease-side-effect pairs result (p-value<0.01). (a) The number of side effects per disease (therapeutic indication). (b) The number of diseases (therapeutic indications) per side effect.

Similar articles

Cited by

References

    1. Adams CP, Brantner VV. Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood) 2006;25(2):420–428. - PubMed
    1. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:682–690. - PubMed
    1. Chiang AP, Butte AJ. Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther. 2009;86(5):507–510. - PMC - PubMed
    1. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175–181. - PMC - PubMed
    1. Li J, Zhu X, Chen JY. Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts. PLoS Comput Biol. 2009;5(7):e1000450. - PMC - PubMed

Publication types

LinkOut - more resources